RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pacific Biosciences of California Stock

Pacific Biosciences of California ROCE 2024

Pacific Biosciences of California ROCE

-0.46

Ticker

PACB

ISIN

US69404D1081

WKN

A1C3EQ

In 2024, Pacific Biosciences of California's return on capital employed (ROCE) was -0.46, a -14.85% increase from the -0.54 ROCE in the previous year.

Pacific Biosciences of California Aktienanalyse

What does Pacific Biosciences of California do?

Pacific Biosciences of California Inc is an American biotechnology company specializing in the development of systems for DNA sequencing and genome research. The company was founded in 2004 and is headquartered in Menlo Park, California. The company was founded by biochemist Stephen Turner, who had previously worked at Illumina, a leading company in genome research. The goal was to develop a new technology for DNA sequencing that would be faster and more accurate than existing systems. In 2005, the company received investments from notable venture capitalists such as Mohr Davidow Ventures, Alloy Ventures, and Kleiner Perkins Caufield & Byers. In 2010, Pacific Biosciences released its first commercial DNA sequencing system. The business model of Pacific Biosciences is based on the development and marketing of DNA sequencing systems and related products and services. The company offers standalone devices as well as integrated solutions for genome research to its customers, including research and diagnostic laboratories. Pacific Biosciences focuses on long-term customer relationships and the continuous advancement of its technologies. Pacific Biosciences operates in two main business segments: research and diagnostics. In the research segment, the company offers DNA sequencing systems that help researchers decipher the DNA of individual cells and complex genomes. These systems enable scientists to deepen their understanding of molecular-level biological processes and diseases. In the diagnostics segment, Pacific Biosciences develops solutions for personalized medicine and application in clinical laboratories. The main product of Pacific Biosciences is the PacBio RS II DNA sequencing platform. This system is based on the single-molecule sequencing technology, which offers high accuracy and reading speed. The PacBio RS II is a fully integrated device that performs both DNA preparation and sequencing, simplifying the entire workflow. In addition, Pacific Biosciences also offers a variety of products and services tailored to the needs of its customers. These include DNA extraction kits, sequencing software, and analysis tools. In summary, Pacific Biosciences of California is a biotechnology company specializing in the development of systems for DNA sequencing and genome research. Founded in 2004, the company is headquartered in Menlo Park, California. Pacific Biosciences operates in two main business segments, research and diagnostics, and offers a variety of products and services tailored to the needs of its customers. The main product of Pacific Biosciences is the PacBio RS II DNA sequencing platform, based on single-molecule sequencing technology. Pacific Biosciences of California ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Pacific Biosciences of California's Return on Capital Employed (ROCE)

Pacific Biosciences of California's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Pacific Biosciences of California's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Pacific Biosciences of California's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Pacific Biosciences of California’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Pacific Biosciences of California stock

What is the ROCE (Return on Capital Employed) of Pacific Biosciences of California this year?

The ROCE of Pacific Biosciences of California is -0.46 undefined this year.

How has the ROCE (Return on Capital Employed) of Pacific Biosciences of California developed compared to the previous year?

The ROCE of Pacific Biosciences of California has increased by -14.85% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Pacific Biosciences of California?

A high Return on Capital Employed (ROCE) indicates that Pacific Biosciences of California has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Pacific Biosciences of California?

A low ROCE (Return on Capital Employed) can indicate that Pacific Biosciences of California has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Pacific Biosciences of California impact the company?

An increase in the ROCE of Pacific Biosciences of California can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Pacific Biosciences of California affect the company?

A decrease in ROCE of Pacific Biosciences of California can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Pacific Biosciences of California?

Some factors that can affect Pacific Biosciences of California's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Pacific Biosciences of California so important for investors?

The ROCE of Pacific Biosciences of California is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Pacific Biosciences of California take to improve the ROCE?

To improve the ROCE, Pacific Biosciences of California can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Pacific Biosciences of California pay?

Over the past 12 months, Pacific Biosciences of California paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pacific Biosciences of California is expected to pay a dividend of 0 USD.

What is the dividend yield of Pacific Biosciences of California?

The current dividend yield of Pacific Biosciences of California is .

When does Pacific Biosciences of California pay dividends?

Pacific Biosciences of California pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pacific Biosciences of California?

Pacific Biosciences of California paid dividends every year for the past 0 years.

What is the dividend of Pacific Biosciences of California?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pacific Biosciences of California located?

Pacific Biosciences of California is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pacific Biosciences of California kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pacific Biosciences of California from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Pacific Biosciences of California pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of Pacific Biosciences of California in the year 2023?

In the year 2023, Pacific Biosciences of California distributed 0 USD as dividends.

In which currency does Pacific Biosciences of California pay out the dividend?

The dividends of Pacific Biosciences of California are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Pacific Biosciences of California stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Pacific Biosciences of California

Our stock analysis for Pacific Biosciences of California Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pacific Biosciences of California Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.